Daniel Kwon MD (@danielkwonmd) profile picture

Daniel Kwon MD

@danielkwonmd

GU and hospital-based oncology @UCSFCancer 👉patient decision-making support and survivorship

Joined September 2019
  • Tweets72
  • Following59
  • Followers172
🎉 Great work @Kevin_Reyes650, @danielkwonmd and team describing the decision-related needs of people newly diagnosed with #cancer while hospitalized. Multiple perspectives included: patients, caregivers, oncologists. Check it out: pubmed.ncbi.nlm.nih.gov/3868… @UCSFCancer @UCSFDHM
2
1
13
1,784
So excited for @UCSFMedicine 1st year medical student Joy Huang who is an amazing researcher! I’m lucky to have connected with her. 🙌🍀 #ASCO23
Image from Sam Brondfield, MD, MAEd, FASCO (@s_brond)
2
26
1,374
Daniel Kwon MD retweeted
UroToday.com (@urotoday) profile picture
UroToday.com
@urotoday14 Feb 2023
Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > bit.ly/3gO41cw @UrolOncol @mbucknor @HalaBorno
Image from UroToday.com (@urotoday)
1
2
1,250
Daniel Kwon MD retweeted
UroToday.com (@urotoday) profile picture
UroToday.com
@urotoday17 Jan 2023
Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > bit.ly/3gO41cw @UrolOncol @mbucknor @HalaBorno
Image from UroToday.com (@urotoday)
1
2
1,019
Daniel Kwon MD retweeted
UroToday.com (@urotoday) profile picture
UroToday.com
@urotoday19 Dec 2022
Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with @danielkwonmd @UCSFCancer on UroToday > bit.ly/3gO41cw @UrolOncol @mbucknor @HalaBorno
Image from UroToday.com (@urotoday)
2
2
1,039
Daniel Kwon MD retweeted
Thomas Hope (@thomashopemd) profile picture
Thomas Hope@thomashopemd4 May 2022
It's rough to wait so long to get 177Lu-PSMA-617 therapy available, and then see a patient who is in such need with a scan that would suggest great benefit (SUVs in the 60s), and then find out that doses can't be delivered for an unknown amount of time. Unbelievable!
Image from Thomas Hope (@thomashopemd)
13
15
3
94
Daniel Kwon MD retweeted
Thomas Hope (@thomashopemd) profile picture
Thomas Hope@thomashopemd23 Mar 2022
Finally! FDA approves 177Lu-PSMA-617. Somewhat odd name (Pluvicto). Can't wait to see the prescribing information.
12
48
4
255
COVID‐19 outcomes in patients with cancer: Findings from the University of California health system database | @danielkwonmd @FranklinHuang in the journal Cancer Medicine onlinelibrary.wiley.com/doi/… #openaccess
COVID‐19 outcomes in patients with cancer: Findings from the University of California health system...

COVID‐19 outcomes in patients with cancer: Findings from the University of California health system...

In a large dataset of patients who underwent SARS-CoV-2 testing across 17 California medical centers, we conducted multivariable analyses to evaluate cancer-related risk factors for poor COVID-19...

onlinelibrary.wiley.com
1
2
4
Hey #oncologists and @HemOncFellows! We’re recruiting a new @UCSFHospitals hospital-based oncologist (#HBO)! Come join our growing inpatient solid onc group w @danielkwonmd and me @UCSFCancer 🥰 Apply: bit.ly/HBOfacultyrecruit Why I ❤️ #HBO: bit.ly/HBOtheOncologist 🩺🥼🏥🥰
7
22
Daniel Kwon MD retweeted
Tyler Johnson (@tpjmd) profile picture
Tyler Johnson@tpjmd3 Feb 2022
mercurynews.com/2022/02/03/8… thanks to the Mercury News for publishing my reflection on what doctoring has taught me about processing the irreplaceable losses of the pandemic.
Opinion: The great truth doctoring has taught me about death

Opinion: The great truth doctoring has taught me about death

Shared presence — really being there with and for each other — at a moment of loss can sanctify sorrow.

mercurynews.com
3
1
3
13
Hiring AHP (NP/PA) for @UCSFCancer hospital-based oncology #HBO service! Internal and external AHPs welcome: bit.ly/UCSFNPint bit.ly/UCSFNPext bit.ly/UCSFPAint bit.ly/UCSFPAext Work w sweet (@danielkwonmd) and sassy (🙋🏻‍♂️) attendings 😝 @UCSFHospitals
5
13
Two years into the #COVID19 pandemic & we are still worrying about all the missed #hemeonc fellow professional & career development opportunities! Excited to see our work in @JCOOP_ASCO ascopubs.org/doi/full/10.120… highlighting PD #burnout & perspectives on #fellowship needs
Image from Ana I. Velázquez Mañana, MD, MSc, FASCO (@AnaVManana)
6
30
5
97
A mobile application for pts to record consults was feasible, acceptable, and a potentially valued intervention to improve decision making in the #telehealth setting for men w/ #prostatecancer. fal.cn/3l9BG #pcsm #JCOOP @danielkwonmd
Image from JCO Oncology Practice (@JCOOP_ASCO)
6
2
14
Daniel Kwon MD retweeted
Vadim Koshkin MD (@koshkin85) profile picture
Vadim Koshkin MD
@koshkin8526 May 2021
Thank you @JournalCancer for highlighting work with @danielkwonmd @HemoncUcsf of outcomes in mCRPC patients with DDR mutations, a multi-institutional effort @UCSFCancer @UCSFMedicine @UMRogelCancer @UBCmedicine @PCFnews @PCF_Science
ACS Journal Cancer (@JournalCancer) profile pictureACS Journal Cancer@JournalCancer25 May 2021
Read our June 15 issue today! 📗 acsjournals.onlinelibrary.wi… In this issue: ➡️ @koshkin85 et al on differential tx outcomes in mCRPC ➡️ @BrainMets_MSK investigators on MBMs in the age of adv treatments ➡️ @DrFadloKhuri's reflection on the past 10 years as our Editor-in-Chief
Image from ACS Journal Cancer (@JournalCancer)
6
14
Daniel Kwon MD retweeted
London Breed (@LondonBreed) profile picture
London Breed
@LondonBreed4 May 2021
Use your best judgment. If you're fully vaccinated, outdoors, and not in a large crowd, there is no need to wear a mask. If you’re indoors with people who may not be vaccinated, keep your mask on.
13
34
8
223
New Platinum Opinion from @danielkwonmd Chris Booth @VPrasadMDMPH Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib? buff.ly/3vnJ0Ye
Image from European Urology (@EUplatinum)
8
25
This retrospective analysis of 149 pts w/ DNA repair-mutated metastatic castration‐resistant #ProstateCancer highlights differential treatment outcomes to standard tx that informs discussions & clinical trial design. ow.ly/ecGd50DW7dM @danielkwonmd @koshkin85 @UCSFCancer
Image from ACS Journal Cancer (@JournalCancer)
Image from ACS Journal Cancer (@JournalCancer)
3
1
5
Daniel Kwon MD retweeted
UCSF IHPS (@UCSF_IHPS) profile picture
UCSF IHPS@UCSF_IHPS12 Feb 2021
Have you ever considered the role that trained undergraduate students can play in expanding the accessibility of #psychosocial resources? Learn more in this #IHPS2021 #Tweetorial by @GroupPatient @jeffbelkora @diannesf 1/6
1
7
1
10
Impressive work by @danielkwonmd: 1) No relationship between receipt of ADT and SARS-CoV-2 infection. 2) Increased risk of COVID-19 infection in Hispanic and Black patients, echoing results from our work in @Cancer_Cell. @ASCO #GU21 @UCSF Poster + video: meetinglibrary.asco.org/reco…
Image from Ziad Bakouny, MD, MSc (@ZiadBakouny)
Image from Ziad Bakouny, MD, MSc (@ZiadBakouny)
Image from Ziad Bakouny, MD, MSc (@ZiadBakouny)
1
9
2
24
Daniel Kwon MD retweeted
Julie Wu (@julie_t_wu) profile picture
Julie Wu@julie_t_wu14 Jan 2021
Our JCO OP paper on cancer management of COVID-19 infected patients made it into ASCO Post! @sumitshahMD @l_schapira @glovedoc @danielkwonmd @koshkin85 @hemoncwarner @StanfordCancer @COVID19nCCC ascopost.com/news/january-20…
Effect of COVID-19 Infection on Cancer Management

Effect of COVID-19 Infection on Cancer Management

In a study reported in JCO Oncology Practice, Wu et al found that almost two-thirds of patients undergoing active cancer management who were diagnosed with COVID-19 over a 4-month period in 2020 had...

ascopost.com
3
1
6
Load more